Polish Pharmacoeconomic Society sections continue working on already initiated projects and have started discussions about next year focus.
The most recent news is that the Polish ISPOR Chapter finalized the translation of the ISPOR book on Therapeutic and Diagnostic Device Outcomes Research and the Health Related Quality of Life Section (HRQoL) finalized working on the Quality of Life Dictionary. Both books were published and made available at the Polish ISPOR Chapter Conference in December 2014.
The Therapeutic Programs, Pharmaceutical Care and Pharmaceutical Law Section (TPPCPL) continue to analyze adverse events costs based on therapeutic programs examples and started discussions on initiating different projects in 2015. Among other proposals Section there is a suggestion inspired by the HRQoL to work on pricing related terms in Polish language.
The Polish Pharmacoeconomic Society also continues to support the Journal of Health Policy and Outcomes Research (JHPOR) and after the successful Scientific Conference in 2014, JHPOR already started preparations to organize the 2nd Scientific Conference dedicated to “Registries". The conference will take place in Warsaw on 19 th March 2015 and will be a forum to discuss real world data needs in Poland. An interdisciplinary input into the discussion is expected.
In December 2014 the Polish Society for Pharmacoeconomics organized the 12th International Conference dedicated to "Effective health care, how to make it profitable?".
The conference was focused on important issues related to healthcare in Poland and in Europe. There were sessions about risk sharing instruments, about a new approach to decision-making process based on Multi-Criteria Decision Analysis, exploring the possibilities of their practical implementation in the health care system. Another topic at the conference was dedicated to the functioning of the drug programs in Poland, from both the clinical perspective on basis of concrete examples and the National Health Fund’s perspective.
There were sessions dedicated to health outcomes in oncology with particular emphasis on the analysis of survival and sessions about indirect costs in health care and methodology for measuring indirect costs.
Special guest invited to the conference was professor Michael Drummond, who gave a plenary lecture during which he summarized the most significant financial challenges European countries are facing. He also shared some experiences of other European countries in relation to Risk Sharing Agreements and Value-based Pricing.